Oral Food Challenge Protocols in Food Protein-Induced Enterocolitis Syndrome: A Systematic Review.

Tayseer Ibrahim, Laura Argiz, Sonsoles Infante, Stefania Arasi, Ulugbek Nurmatov, Marta Vazquez-Ortiz
{"title":"Oral Food Challenge Protocols in Food Protein-Induced Enterocolitis Syndrome: A Systematic Review.","authors":"Tayseer Ibrahim, Laura Argiz, Sonsoles Infante, Stefania Arasi, Ulugbek Nurmatov, Marta Vazquez-Ortiz","doi":"10.1016/j.jaip.2024.12.033","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Oral Food Challenges (OFC) are essential for the diagnosis and follow-up of acute Food Protein-Induced Enterocolitis Syndrome (FPIES) because no diagnostic or prognostic biomarkers are available. However, the optimal OFC procedure remains unclear.</p><p><strong>Objectives: </strong>This systematic review aimed to assess OFC procedures' design and clinical outcomes in patients with FPIES.</p><p><strong>Methods: </strong>Ten databases were searched for studies published in English between 1978 and February 2024 involving children or adults undergoing OFC for FPIES. Critical appraisal followed Effective Public Health Practice Project parameters.</p><p><strong>Results: </strong>Fifty-two studies met the inclusion criteria, all observational studies. Of these, 35 were judged to have strong methodological quality. There was great heterogeneity in OFC procedures, particularly in cumulative dose, number, size, and timing between doses. OFC outcome reporting was often inadequate, especially regarding reaction symptoms and severity grading. In single-dose OFC protocols, most children reacted after at least two hours. Four small studies showed that a single dose of 25% of an age-appropriate portion was sufficient to trigger reactions in 80-100% of cases, and this was associated with less severe reactions. Due to methodological heterogeneity and insufficient outcome reporting, further assessment of the OFC protocol characteristics associated with safer outcomes was not possible.</p><p><strong>Conclusion: </strong>There is significant heterogeneity in FPIES OFC practices. Current recommendations on OFC procedures and outcome assessments have limitations and should be revisited, as this may impact patient safety and diagnostic accuracy. Future studies should focus on standardizing clinical outcomes and generating evidence to support safer, more accurate OFC protocols in FPIES.</p>","PeriodicalId":51323,"journal":{"name":"Journal of Allergy and Clinical Immunology-In Practice","volume":" ","pages":""},"PeriodicalIF":8.2000,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Allergy and Clinical Immunology-In Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jaip.2024.12.033","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Oral Food Challenges (OFC) are essential for the diagnosis and follow-up of acute Food Protein-Induced Enterocolitis Syndrome (FPIES) because no diagnostic or prognostic biomarkers are available. However, the optimal OFC procedure remains unclear.

Objectives: This systematic review aimed to assess OFC procedures' design and clinical outcomes in patients with FPIES.

Methods: Ten databases were searched for studies published in English between 1978 and February 2024 involving children or adults undergoing OFC for FPIES. Critical appraisal followed Effective Public Health Practice Project parameters.

Results: Fifty-two studies met the inclusion criteria, all observational studies. Of these, 35 were judged to have strong methodological quality. There was great heterogeneity in OFC procedures, particularly in cumulative dose, number, size, and timing between doses. OFC outcome reporting was often inadequate, especially regarding reaction symptoms and severity grading. In single-dose OFC protocols, most children reacted after at least two hours. Four small studies showed that a single dose of 25% of an age-appropriate portion was sufficient to trigger reactions in 80-100% of cases, and this was associated with less severe reactions. Due to methodological heterogeneity and insufficient outcome reporting, further assessment of the OFC protocol characteristics associated with safer outcomes was not possible.

Conclusion: There is significant heterogeneity in FPIES OFC practices. Current recommendations on OFC procedures and outcome assessments have limitations and should be revisited, as this may impact patient safety and diagnostic accuracy. Future studies should focus on standardizing clinical outcomes and generating evidence to support safer, more accurate OFC protocols in FPIES.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
食物蛋白诱导的肠结肠炎综合征的口服食物挑战方案:系统综述。
背景:口腔食物挑战(OFC)对于急性食物蛋白性小肠结肠炎综合征(FPIES)的诊断和随访至关重要,因为没有可用的诊断或预后生物标志物。然而,最佳的OFC程序仍不清楚。目的:本系统综述旨在评估OFC手术的设计和FPIES患者的临床结果。方法:检索了10个数据库,检索了1978年至2024年2月期间发表的涉及儿童或成人因FPIES接受OFC的英文研究。关键评估遵循有效公共卫生实践项目参数。结果:52项研究符合纳入标准,均为观察性研究。其中,35个被认为具有很强的方法质量。OFC程序存在很大的异质性,特别是在累积剂量、数量、大小和剂量间隔时间方面。OFC结果报告往往不充分,特别是关于反应症状和严重程度分级。在单剂量OFC方案中,大多数儿童在至少两小时后出现反应。四项小型研究表明,在80-100%的病例中,单次剂量为适龄部分的25%就足以引发反应,并且与较轻的反应相关。由于方法的异质性和不充分的结果报告,无法进一步评估与更安全结果相关的OFC方案特征。结论:FPIES的OFC实践存在显著的异质性。目前关于OFC程序和结果评估的建议有局限性,应该重新审视,因为这可能影响患者安全和诊断准确性。未来的研究应侧重于标准化临床结果和产生证据,以支持更安全、更准确的FPIES OFC方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
11.10
自引率
9.60%
发文量
683
审稿时长
50 days
期刊介绍: JACI: In Practice is an official publication of the American Academy of Allergy, Asthma & Immunology (AAAAI). It is a companion title to The Journal of Allergy and Clinical Immunology, and it aims to provide timely clinical papers, case reports, and management recommendations to clinical allergists and other physicians dealing with allergic and immunologic diseases in their practice. The mission of JACI: In Practice is to offer valid and impactful information that supports evidence-based clinical decisions in the diagnosis and management of asthma, allergies, immunologic conditions, and related diseases. This journal publishes articles on various conditions treated by allergist-immunologists, including food allergy, respiratory disorders (such as asthma, rhinitis, nasal polyps, sinusitis, cough, ABPA, and hypersensitivity pneumonitis), drug allergy, insect sting allergy, anaphylaxis, dermatologic disorders (such as atopic dermatitis, contact dermatitis, urticaria, angioedema, and HAE), immunodeficiency, autoinflammatory syndromes, eosinophilic disorders, and mast cell disorders. The focus of the journal is on providing cutting-edge clinical information that practitioners can use in their everyday practice or to acquire new knowledge and skills for the benefit of their patients. However, mechanistic or translational studies without immediate or near future clinical relevance, as well as animal studies, are not within the scope of the journal.
期刊最新文献
Evaluation of Mast Cell Disease in Women: A Case Study of Delayed Diagnosis of Systemic Mastocytosis. Models of inpatient antibiotic allergy management in healthcare. Poor agreement among asthma specialists on the choice and timing of initiation of a biologic treatment for severe asthma patients. Serum Sickness-Like Reactions in children taking antibiotics represent a distressing form of infection- associated urticaria and may recur unpredictably in susceptible children. The role of IgE sensitisation in acute FPIES: A systematic review and meta-analysis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1